U.S., May 14 -- ClinicalTrials.gov registry received information related to the study (NCT07584720) titled 'Study of Midomafetamine in Healthy Adults' on April 30.
Brief Summary: This Phase 1 study is designed to evaluate the safety and tolerability of midomafetamine in healthy adult participants. The study will also assess how the drug is processed in the body and characterize its effects following administration at two dose levels, including evaluation of cardiac safety using electrocardiographic assessments.
This is a single-center, open-label study in which participants will be enrolled into one of two cohorts receiving either a therapeutic dose or a supratherapeutic dose of midomafetamine. Participants will receive study drug in a sp...